NASDAQ:MASS 908 Devices (MASS) Stock Price, News & Analysis → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free MASS Stock Alerts $6.85 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$6.77▼$7.0350-Day Range$5.56▼$7.5552-Week Range$4.85▼$12.51Volume221,189 shsAverage Volume205,507 shsMarket Capitalization$236.22 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get 908 Devices alerts: Email Address 908 Devices MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside104.4% Upside$14.00 Price TargetShort InterestBearish5.36% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.08Based on 6 Articles This WeekInsider TradingAcquiring Shares$178,500 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($1.11) to ($0.95) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.26 out of 5 starsMedical Sector310th out of 918 stocksMedical Devices Industry2nd out of 5 stocks 3.5 Analyst's Opinion Consensus Rating908 Devices has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst Coverage908 Devices has only been the subject of 1 research reports in the past 90 days.Read more about 908 Devices' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.36% of the float of 908 Devices has been sold short.Short Interest Ratio / Days to Cover908 Devices has a short interest ratio ("days to cover") of 7.6.Change versus previous monthShort interest in 908 Devices has recently increased by 8.94%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend Yield908 Devices does not currently pay a dividend.Dividend Growth908 Devices does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MASS. Previous Next 3.9 News and Social Media Coverage News Sentiment908 Devices has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.42 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for 908 Devices this week, compared to 1 article on an average week.Search Interest5 people have searched for MASS on MarketBeat in the last 30 days. MarketBeat Follows2 people have added 908 Devices to their MarketBeat watchlist in the last 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 908 Devices insiders have bought more of their company's stock than they have sold. Specifically, they have bought $178,500.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders27.80% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about 908 Devices' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for 908 Devices are expected to grow in the coming year, from ($1.11) to ($0.95) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of 908 Devices is -6.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 908 Devices is -6.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratio908 Devices has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about 908 Devices' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About 908 Devices Stock (NASDAQ:MASS)908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Read More MASS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MASS Stock News HeadlinesMay 14, 2024 | insidertrades.comKevin J. Knopp Purchases 10,000 Shares of 908 Devices Inc. (NASDAQ:MASS) StockMay 10, 2024 | insidertrades.com908 Devices Inc. (NASDAQ:MASS) CEO Acquires $58,300.00 in StockMay 8, 2024 | insidertrades.comInsider Buying: 908 Devices Inc. (NASDAQ:MASS) CEO Acquires 10,000 Shares of StockMay 16, 2024 | americanbankingnews.comShort Interest in 908 Devices Inc. (NASDAQ:MASS) Expands By 8.9%May 15, 2024 | businesswire.com908 Devices to Participate in Upcoming Investor ConferencesMay 15, 2024 | americanbankingnews.com908 Devices (NASDAQ:MASS) Rating Reiterated by StephensMay 14, 2024 | finance.yahoo.comWall Street Analysts Predict a 133.69% Upside in 908 Devices (MASS): Here's What You Should KnowMay 14, 2024 | americanbankingnews.com908 Devices Inc. (NASDAQ:MASS) CEO Kevin J. Knopp Buys 10,000 SharesMay 1, 2024 | finance.yahoo.com908 Devices Inc. (NASDAQ:MASS) Q1 2024 Earnings Call TranscriptMay 1, 2024 | bizjournals.comFive things: Kendall construction suit, Bay State Banner, Boston Dynamics and the best time to visit Mount Auburn CemeteryMay 1, 2024 | finance.yahoo.com908 Devices Inc (MASS) (Q1 2024) Earnings Call Transcript Highlights: Strategic Acquisitions ...May 1, 2024 | finance.yahoo.comQ1 2024 908 Devices Inc. Earnings CallApril 30, 2024 | bizjournals.com908 Devices buys 'chemical ID' company for up to $76.2MApril 30, 2024 | msn.comMASS Stock Earnings: 908 Devices Beats EPS, Beats Revenue for Q1 2024April 30, 2024 | finance.yahoo.com908 Devices Inc (MASS) Q1 2024 Earnings: Narrower Losses and Revenue GrowthApril 30, 2024 | msn.com908 Devices beats top-line and bottom-line estimates; updates FY24 outlookApril 30, 2024 | finance.yahoo.com908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue OutlookApril 30, 2024 | businesswire.com908 Devices Acquires RedWave Technology, Expanding its Forensics Product OfferingApril 29, 2024 | markets.businessinsider.com908 Devices earnings preview: what to expectApril 29, 2024 | msn.com908 Devices Q1 2024 Earnings PreviewApril 23, 2024 | businesswire.com908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024April 19, 2024 | msn.comThis Porsche 908/02 “Flunder” Never FlounderedMarch 28, 2024 | msn.comThe drug users being given phones to rebuild their livesMarch 16, 2024 | finance.yahoo.comMASS Apr 2024 7.500 callMarch 14, 2024 | msn.comChina responds to TikTok ban: 'This will inevitably backfire on the U.S.'See More Headlines Receive MASS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/30/2024Today5/21/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolNASDAQ:MASS CUSIPN/A CIK1555279 Webwww.908devices.com Phone857-254-1500FaxN/AEmployees230Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$14.00 Low Stock Price Target$14.00 Potential Upside/Downside+104.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,400,000.00 Net Margins-68.57% Pretax Margin-69.12% Return on Equity-20.87% Return on Assets-17.13% Debt Debt-to-Equity RatioN/A Current Ratio8.37 Quick Ratio7.53 Sales & Book Value Annual Sales$50.73 million Price / Sales4.66 Cash FlowN/A Price / Cash FlowN/A Book Value$5.11 per share Price / Book1.34Miscellaneous Outstanding Shares34,485,000Free Float24,898,000Market Cap$236.22 million OptionableOptionable Beta1.02 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Kevin J. Knopp Ph.D. (Age 51)Co-Founder, CEO, President & Director Comp: $761.12kMr. Joseph H. Griffith IV (Age 49)CFO & Treasurer Comp: $491.89kMr. Michael S. Turner Esq. (Age 57)J.D., Chief Legal & Administrative Officer and Secretary Comp: $470.65kDr. Christopher David Brown Ph.D. (Age 49)Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board Comp: $459.7kMr. Steve AraizaCo-FounderMr. Andrew BartfayCo-Founder & Director of Hardware DevelopmentMr. Michael JobinCo-Founder & Director of Product DevelopmentDr. Scott Miller Ph.D.Co-Founder & Director of MS EngineeringMs. Barbara Russo (Age 61)Vice President of Marketing & Corporate Communications Mr. Don Osmer (Age 58)Vice President of Human Resources More ExecutivesKey CompetitorsAngioDynamicsNASDAQ:ANGOPyxis OncologyNASDAQ:PYXSUtah Medical ProductsNASDAQ:UTMDAldeyra TherapeuticsNASDAQ:ALDXMetagenomiNASDAQ:MGXView All CompetitorsInsiders & InstitutionsIron Triangle Partners LPSold 244,179 shares on 5/16/2024Ownership: 3.018%AWM Investment Company Inc.Bought 15,058 shares on 5/16/2024Ownership: 1.939%Platinum Investment Management Ltd.Sold 409,571 shares on 5/14/2024Ownership: 1.079%Kevin J KnoppBought 10,000 shares on 5/13/2024Total: $64,200.00 ($6.42/share)Vanguard Group Inc.Bought 6,772 shares on 5/10/2024Ownership: 5.310%View All Insider TransactionsView All Institutional Transactions MASS Stock Analysis - Frequently Asked Questions Should I buy or sell 908 Devices stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MASS shares. View MASS analyst ratings or view top-rated stocks. What is 908 Devices' stock price target for 2024? 1 brokers have issued 1-year price targets for 908 Devices' stock. Their MASS share price targets range from $14.00 to $14.00. On average, they predict the company's stock price to reach $14.00 in the next year. This suggests a possible upside of 104.4% from the stock's current price. View analysts price targets for MASS or view top-rated stocks among Wall Street analysts. How have MASS shares performed in 2024? 908 Devices' stock was trading at $11.22 on January 1st, 2024. Since then, MASS stock has decreased by 38.9% and is now trading at $6.85. View the best growth stocks for 2024 here. When is 908 Devices' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our MASS earnings forecast. How were 908 Devices' earnings last quarter? 908 Devices Inc. (NASDAQ:MASS) announced its quarterly earnings results on Tuesday, April, 30th. The company reported ($0.33) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.03. The business earned $9.99 million during the quarter, compared to analysts' expectations of $9.29 million. 908 Devices had a negative trailing twelve-month return on equity of 20.87% and a negative net margin of 68.57%. 908 Devices's revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the business posted ($0.39) earnings per share. What ETFs hold 908 Devices' stock? ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include Alger 35 ETF (ATFV).ARK Genomic Revolution ETF (ARKG). What guidance has 908 Devices issued on next quarter's earnings? 908 Devices issued an update on its FY 2024 earnings guidance on Tuesday, April, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $63.0 million-$65.0 million, compared to the consensus revenue estimate of $52.9 million. When did 908 Devices IPO? 908 Devices (MASS) raised $101 million in an initial public offering on Friday, December 18th 2020. The company issued 6,300,000 shares at $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair acted as the underwriters for the IPO. Who are 908 Devices' major shareholders? 908 Devices' stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (5.31%), Iron Triangle Partners LP (3.02%), AWM Investment Company Inc. (1.94%), Nikko Asset Management Americas Inc. (1.70%), Sumitomo Mitsui Trust Holdings Inc. (1.71%) and Platinum Investment Management Ltd. (1.08%). Insiders that own company stock include Christopher D Brown, Christopher D Brown, John Kenneweg, Joseph H Iv Griffith, Kevin J Knopp, Mark Spoto, Michael S Turner, Nicolas Barthelemy, Trent A Basarsky and Trent A Basarsky. View institutional ownership trends. How do I buy shares of 908 Devices? Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MASS) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 908 Devices Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
